News

Roche is committing $50 billion over the next five years for new research and development sites across the country, and the ...
Roche is pledging to invest $50 billion in manufacturing and research infrastructure in the U.S. over the next five years, ...
Roche is committing $50 billion over the next five years for new research and development sites across the country, and the ...
Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...
Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...
The big pharma joined several of its peers in committing to invest billions of dollars in new and expanded manufacturing ...
The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...
With the threat of pharmaceutical tariffs hanging over the biopharmaceutical industry, Roche is the latest addition to a ...
INDIANAPOLIS — Roche, a Swiss biotechnology company whose U.S. headquarters is in Indianapolis, has announced its intention ...
Swiss drugmaker Roche (RHHBY) announced its decision to invest $50 billion in the U.S. towards pharmaceuticals and ...
The Basel-based company said the investment would go toward high-tech research and development sites and new manufacturing ...
Roche said Indiana would receive a new manufacturing facility for continuous glucose monitoring and expansion and upgrades at existing pharmaceutical, diagnostics and distribution operations.